Huichuan Yang
China National Pharmaceutical Group Corporation (China)(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, COVID-19 Impact on Reproduction, Hepatitis C virus research
Most-Cited Works
- → Effectiveness of convalescent plasma therapy in severe COVID-19 patients(2020)2,023 cited
- → The feasibility of convalescent plasma therapy in severe COVID- 19 patients: a pilot study(2020)129 cited
- → Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan(2021)69 cited
- → Cinnamylphenols from Phyllodium pulchellum(2005)42 cited
- → Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma(2022)11 cited
- → Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan(2021)7 cited
- → Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID(2023)5 cited
- → The self-reported experiences of siblings who have a brother or sister diagnosed with childhood cancer: a systematic review protocol of qualitative evidence(2013)2 cited
- → Epilepsy Interview Guide(2010)